These hub nodes such as VEGFA, EGFR, ESR1, PLG, and MAPK3 were mainly enriched in pathways like proteoglycans in cancer, bladder cancer, and estrogen-signaling pathway. This evidence concerns the gene PLG and urinary bladder carcinoma.